Source: Eur Respir J 2016; 48: 1160-1170
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mitnick Carole D., White Richard A., Lu Chunling, Rodriguez Carly A., Bayona Jaime, Becerra Mercedes C., Burgos Marcos, Centis Rosella, Cohen Theodore, Cox Helen, D'Ambrosio Lia, Danilovitz Manfred, Falzon Dennis, Gelmanova Irina Y., Gler Maria T., Grinsdale Jennifer A., Holtz Timothy H., Keshavjee Salmaan, Leimane Vaira, Menzies Dick, Migliori Giovanni Battista, Milstein Meredith B., Mishustin Sergey P., Pagano Marcello, Quelapio Maria I., Shean Karen, Shin Sonya S., Tolman Arielle W., van der Walt Martha L., Van Deun Armand, Viiklepp Piret. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J 2016; 48: 1160-1170

Member's Comments

No comment yet.

Related content which might interest you: Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006 Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST. Source: International Congress 2017 – MDRTB: detection and management Year: 2017 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Effect of fluoroquinolones on microbiologic outcome and survival in the treatment of multidrug-resistant tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006 Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 41: 1393-1400 Year: 2013 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Rapid resistance detection of Mycobacterium tuberculosis to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system. Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Early detection and monitoring of progressive neonatal multidrug-resistant M. tuberculosis infection by T cell-based assay Source: Eur Respir J 2004; 24: Suppl. 48, 206s Year: 2004 The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study Source: Eur Respir J 2015; 46: 567-570 Year: 2015 Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007 Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009